FDA Adverse Event Injury Summary report: N

LIVIAN

MDR report key: 2930097 · Received January 25, 2013

Report

Report Number
2124215-2013-01913
Event Type
Injury
Date Received
January 25, 2013
Date of Event
December 18, 2012
Report Date
March 31, 2014
Manufacturer
GUIDANT CRM CLONMEL IRELAND
Product Code
LWP
PMA / PMN Number
P010012
Adverse Event
Yes
Report Source
Manufacturer report
Reporter Occupation
HEALTH PROFESSIONAL

Narratives

Additional Manufacturer Narrative · 1

UPON RECEIPT AT OUR POST MARKET QUALITY ASSURANCE LABORATORY, A THOROUGH EVALUATION OF THE DEVICE WAS PERFORMED. A VISUAL INSPECTION OF THE DEVICE HEADER AND CASE NOTED NO ANOMALIES. THE DEVICE WAS THEN EXPOSED TO SIMULATED HEART LOAD CONDITIONS, AND THE DEFIBRILLATION, PACING AND SENSING FUNCTIONS WERE TESTED. THE DEVICE OPERATED APPROPRIATELY, ACCORDING TO ITS PERFORMANCE SPECIFICATIONS, WITH NO INTERRUPTIONS IN THERAPY OUTPUT OR PROGRAMMER COMMUNICATION AT THE RETURNED PROGRAMMED SETTINGS. A SERIES OF ELECTRICAL TESTS WAS ALSO PERFORMED, AND AGAIN, NORMAL DEVICE FUNCTION WAS OBSERVED.

Additional Manufacturer Narrative · 1

ADDITIONAL INFORMATION WAS RECEIVED THAT THE A NURSING HOME HEALTH CARE PROFESSIONAL (HCP) WAS UNSURE IF THE PATIENT HAD EXPERIENCED A SYNCOPAL EPISODE OR SEIZURE. INTERROGATION OF THE DEVICE REVEALED NO EPISODES THAT CORRELATED WITH THE INCIDENT AND NORMAL DEVICE FUNCTION WAS OBSERVED. ADDITIONALLY, THE PATIENT WAS NOTED TO BE IN CHRONIC ATRIAL FIBRILLATION (AF). THIS PRODUCT REMAINS IMPLANTED AND IN SERVICE. AS NO FURTHER INFORMATION CONCERNING THIS REPORT IS EXPECTED, OUR INVESTIGATION IS COMPLETE. THIS INVESTIGATION WILL BE UPDATED SHOULD FURTHER INFORMATION BE PROVIDED.

Additional Manufacturer Narrative · 1

THE LOCAL AREA SALES REPRESENTATIVE WAS CONTACTED FOR ADDITIONAL INFORMATION. AT THIS TIME, NO FURTHER INFORMATION IS AVAILABLE. SHOULD ADDITIONAL INFORMATION BECOME AVAILABLE THIS REPORT WILL BE UPDATED.

Description of Event or Problem · 1

ADDITIONAL INFORMATION WAS RECEIVED THAT THIS CRT-D WAS ROUTINELY EXPLANTED AND REPLACED. THE DEVICE WAS RETURNED FOR ANALYSIS.

Description of Event or Problem · 1

BOSTON SCIENTIFIC RECEIVED INFORMATION THAT THE PATIENT IMPLANTED WITH THIS CARDIAC RESYNCHRONIZATION THERAPY DEFIBRILLATOR (CRT-D) EXPERIENCED A SYNCOPAL EPISODE AND A SEIZURE. A REMOTE INTERROGATION HAD BEEN COMPLETED AND A HEALTH CARE PROFESSIONAL (HCP) CONTACTED A COMPANY REPRESENTATIVE TO DISCUSS RETRIEVAL OF THE DATA. NO ADDITIONAL ADVERSE PATIENT EFFECTS WERE REPORTED.

Devices

Seq Brand Generic Product Code Manufacturer Model Lot UDI-DI
35691 LIVIAN IMPLANTABLE CHF GENERATOR LWP GUIDANT CRM CLONMEL IRELAND H220

Patients

Seq Age Sex Outcome Treatment
1 83 YR Life Threatening 0157| 4480| 1290| 4542| H220| 4459| 4548